Pages that link to "Q34488529"
Jump to navigation
Jump to search
The following pages link to Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial (Q34488529):
Displaying 50 items.
- Ebola and its control in Liberia, 2014-2015 (Q23922910) (← links)
- The 2014–2015 Ebola outbreak in West Africa: Hands On (Q24049114) (← links)
- Infectious diseases. Beyond Ebola (Q24247077) (← links)
- Vaccinology in the third millennium: scientific and social challenges (Q24261399) (← links)
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA (Q24289279) (← links)
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe (Q24289281) (← links)
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report (Q24289295) (← links)
- Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola (Q24574408) (← links)
- Viral vectors as vaccine platforms: from immunogenicity to impact (Q24574798) (← links)
- Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic (Q24658595) (← links)
- Ebola virus disease and critical illness (Q26250274) (← links)
- Clinical development of Ebola vaccines (Q26775792) (← links)
- Ebolavirus Evolution: Past and Present (Q26777336) (← links)
- Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens (Q27011190) (← links)
- Transforming Clinical Data into Actionable Prognosis Models: Machine-Learning Framework and Field-Deployable App to Predict Outcome of Ebola Patients (Q27077202) (← links)
- Optimal control analysis of Ebola disease with control strategies of quarantine and vaccination (Q27318406) (← links)
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) (Q28051937) (← links)
- Carrion's disease: an eradicable illness? (Q28119690) (← links)
- Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain (Q28223031) (← links)
- Neurological Complications of Ebola Virus Infection (Q28385386) (← links)
- Evaluating interventions for Ebola: The need for randomized trials (Q28388002) (← links)
- Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis (Q28389947) (← links)
- Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection (Q28393073) (← links)
- Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us (Q28397866) (← links)
- CEPI—a new global R&D organisation for epidemic preparedness and response (Q28595117) (← links)
- Both Epistasis and Diversifying Selection Drive the Structural Evolution of the Ebola Virus Glycoprotein Mucin-Like Domain (Q28596689) (← links)
- Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine (Q28822525) (← links)
- Bolstering community cooperation in Ebola resurgence protocols: combining field blood draw and point-of-care diagnosis (Q28950587) (← links)
- A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks (Q29048611) (← links)
- Vaccine testing for emerging infections: the case for individual randomisation (Q29451722) (← links)
- The contribution of biological, mathematical, clinical, engineering and social sciences to combatting the West African Ebola epidemic (Q29994641) (← links)
- A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? (Q29994671) (← links)
- Global research trends of World Health Organization's top eight emerging pathogens (Q30151375) (← links)
- Ebola outbreak preparedness planning: a qualitative study of clinicians' experiences (Q30151407) (← links)
- Back to the Future. Vaccine trials against Ebola in the history of resistance to immunization (Q30151742) (← links)
- Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and Response (Q30196556) (← links)
- The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions (Q30201997) (← links)
- Insights from clinical research completed during the west Africa Ebola virus disease epidemic. (Q30234590) (← links)
- Ebola and Marburg virus vaccines (Q30234637) (← links)
- Key data for outbreak evaluation: building on the Ebola experience (Q30234872) (← links)
- A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus (Q30235073) (← links)
- Prospects for a Zika Virus Vaccine (Q30235612) (← links)
- Immunobiology of Ebola and Lassa virus infections (Q30238887) (← links)
- Molecular mechanisms of Ebola pathogenesis. (Q30243891) (← links)
- Monoclonal antibodies for the treatment of Ebola virus disease (Q30245073) (← links)
- Ebola virus - from neglected threat to global emergency state (Q30245153) (← links)
- Overview of the Ebola vaccines in pre-clinical and clinical development (Q30245207) (← links)
- The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity (Q30251094) (← links)
- Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials (Q30251949) (← links)
- Experimental Therapies for Ebola Virus Disease: What Have We Learned? (Q30275032) (← links)